What we do Phaarmasia Ltd manufactures hormonal oral contraceptive tablets and iron combipacks at WHO-GMP and ISO 9001 certified facilities, serving pharmaceutical markets. |
Founded in 1,981 |
Market share Key player in India's hormonal contraceptive segment with over 30 million units annual manufacturing capacity. |
Problem solved Provides high-quality oral contraceptives and iron supplements to support women's health and family planning needs. |
Top clients or who we serve Serves pharmaceutical distributors and healthcare sectors across India, primarily B2B operations. |
Key management Mr. Naga Bhaskara Rao Yallapragada (Whole-time Director) leads with experienced board including independent directors. |
Our journey and innovations Incorporated in 1981, the company expanded in 1993-94, achieving WHO-GMP certification and mastering hormonal formulations. |
Where we operate Operations focused in India, supplying domestic pharmaceutical markets. |
Top products or what we offer Hormonal oral contraceptive tablets and combipacks combined with iron tablets. |
Top brands Key product lines are contraceptive oral tablets and iron-combipacks, recognized for quality and compliance. |
Raw materials needed Active pharmaceutical ingredients for hormonal and iron formulations, packaging materials. |
Raw materials supplier Suppliers include specialized pharmaceutical raw material firms (undisclosed). |
Recurring vs cyclical contribution Revenue primarily recurring from steady pharmaceutical product demand. |
Our industry position A niche manufacturer in hormonal contraceptives with certified quality standards, operating within Indian pharma industry. |
Financial highlights Revenue at Rs. 24.37 Cr in FY2025 with net loss of Rs. 1.59 Cr, reflecting business challenges. |
Geographical revenue split 100% revenue generated from Indian pharmaceutical markets. |
Order book - |
Whats driving growth Growth driven by consistent demand for contraceptives and nutritional supplements within domestic health sector. |
Our future plans Focus on business expansion and operational efficiencies; no major change in business model reported. |
Our green promise - |
Our people and values Committed to employee welfare and compliant workplace policies fostering talent retention. |
Key challenges ahead Financial losses, regulatory compliance, and market competition pose ongoing challenges. |
Interesting facts One of the few Indian units dedicated to hormonal contraceptive manufacturing with WHO certification. |
Risks and strategy Near-term losses mitigated by cost control; strategic focus on quality manufacturing and market penetration. |
